Injective Token Surges 25% in a Week Amid US Regulatory Talks and Institutional Interest
Injective's native token INJ has seen significant gains following positive regulatory developments and increased institutional adoption.
Injective's native token INJ has seen significant gains following positive regulatory developments and increased institutional adoption. Injective (INJ) is trading at ₹816 ($8.58), up 0.8% since this brief published. This is an original Token Times brief based on reporting by Crypto Economy, with live market data added, as of Fri, 16 Oct 2026 22:00:01 UTC.
The surge in Injective's token price highlights growing investor confidence in platforms that navigate regulatory challenges while attracting institutional interest, potentially signaling broader market shifts.
- INJ price rose 27.3% in one day, reaching $9.13 on October 16.
- Market cap surpassed $914M with 24h trading volume over $340M.
- Recent US regulatory talks and institutional adoption are key drivers.
- Current price at $8.51 reflects sustained momentum.
The native token of the 
Injective blockchain, INJ, has experienced a significant price increase, rising by 27.3% to $9.13 on October 16, according to CoinGecko data reported by Crypto Economy.
This surge has elevated Injective's market capitalization to approximately $914 million, with a 24-hour trading volume surpassing $340 million. The token has maintained its upward trajectory, currently trading at $8.51, reflecting a 24-hour increase of 1.33% and a 7-day gain of 24.96%.
The price movement follows recent discussions with US regulators and growing institutional interest in the platform. These developments suggest that Injective is successfully positioning itself as a compliant and attractive option for institutional investors.
The broader crypto market remains relatively flat, with a total market cap of $2.8 trillion. 
Bitcoin is down 0.60% in the last 24 hours, and the overall market sentiment, as measured by the Fear & Greed Index, is at 63, indicating 'Greed'.
The strong performance of INJ underscores the potential for regulatory clarity and institutional adoption to drive growth in the crypto sector. Investors will be watching for further regulatory developments and institutional partnerships that could sustain this momentum.
Since this brief published about 1 hour ago, Injective (INJ) has moved from ₹809.30$8.51 to ₹815.96$8.58 — +0.82%.
The chart plots INJ's price: grey is the move before this brief published, the vertical dashed line marks the moment it published, the horizontal dashed line is the price then, and the coloured area is the move since — from Token Times's market data (daily resolution). It shows what happened after the news, not that the news caused it; many factors move prices. Not financial advice.
At today's peer-to-peer rate, 1 INJ ≈ ₹885.89 (about $8.58), up 1.3% over 24 hours. The rupee itself trades about 8.6% above the official rate on the P2P market, so a Indian buyer's effective cost differs from the headline dollar price.
Live market data
Current prices for the asset in this story — live, source-stamped, updated every 15 minutes.
Injective Token Surges 25% in a Week Amid US Regulatory Talk — questions & answers
What caused Injective's token price to surge?
The surge was driven by positive US regulatory talks and increased institutional adoption.
How much did Injective's market cap increase?
Injective's market cap rose to approximately $914 million.
What is the current price of INJ?
INJ is currently trading at $8.51, up 1.33% in the last 24 hours.
How much is 1 Injective worth in rupee today?
About ₹885.89 at the live peer-to-peer (P2P) USDT rate, which is what Indians typically trade at — equivalent to roughly $8.58. The rupee price moves with both INJ's US-dollar price and the USDT/INR rate; use our Injective in rupee page for any amount.
Has Injective's price moved since this brief was published?
INJ is up 0.82% since this brief first published — trading at ₹816 ($8.58) now versus ₹809 ($8.51) at publication. Token Times re-checks this figure against CoinGecko and Binance every 15 minutes.
Which outlets reported this story?
This is an original Token Times brief that synthesises reporting from Crypto Economy. It is not a copy of any one article — follow the source links above for the original reporting.
Original summary — not financial advice. This is an original Token Times brief that summarises a development reported elsewhere and adds live market data for context; it is not the original article and reproduces no part of it. Follow the source link above for full details. Crypto is volatile and high-risk — always do your own research.